In J.P. Morgan talk, Insilico Medicine Founder and CEO to reveal new milestones and robotics capabilities
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, will reveal major company milestones...